
|Videos|March 30, 2022
AMCP 2022: Michael Ciarametaro of National Pharmaceutical Council Talks Gene Therapy, Medicaid Best Price Rule
Author(s)MHE Staff
Michael Ciarametaro, MBA, National Pharmaceutical Council National discusses gene therapy and the Medicaid Best Price Rule with MHE during the annual AMCP conference in Chicago.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
2
When it comes to quality measures, fewer is viewed as better, says Ben Shirley of PQA | Part 2
3
Myqorzo is now available for rare heart condition at a $108,400 annual price
4
Don’t let ‘sleepmaxxing’ keep you up at night: Results from the 2025 American Academy of Sleep Medicine survey on sleep tracking
5























